miR-3191 promotes the proliferation and metastasis of hepatocellular carcinoma via regulating PAK6
2024

miR-3191 and its role in liver cancer

Sample size: 293 publication 10 minutes Evidence: high

Author Information

Author(s): Xie Anqi, Wang Hengjie, Huang Jingchen, Sun Minmin, Chen Lin

Primary Institution: Community Health Service Center, Zhongshan Street, Songjiang District, Shanghai, China

Hypothesis

miR-3191 promotes the proliferation and metastasis of hepatocellular carcinoma via regulating PAK6.

Conclusion

miR-3191 promotes the proliferation and metastasis of HCC cells via targeting PAK6 and may serve as a prognostic biomarker and potential therapeutic target.

Supporting Evidence

  • miR-3191 expression was significantly increased in HCC tissues compared with paired non-cancerous tissues.
  • High miR-3191 expression was associated with aggressive clinical features and poor overall survival in HCC patients.
  • Knockdown of miR-3191 inhibited HCC cell proliferation and metastasis in vitro and in vivo.

Takeaway

This study found that a tiny molecule called miR-3191 helps liver cancer cells grow and spread by affecting another protein called PAK6.

Methodology

The study used quantitative real-time PCR, cell proliferation assays, and animal models to investigate the role of miR-3191 in HCC.

Limitations

The study primarily focuses on in vitro and in vivo models, which may not fully replicate human disease complexity.

Participant Demographics

Patients with hepatocellular carcinoma who underwent surgical resection.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s13027-024-00628-w

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication